Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

and removal may jointly be required for longer life

Restoring in and together with removing chronically senescent may be required for lasting . Either intervention meeting the alone would refute the proposed requirement.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionImpaired autophagy

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Candidate set selection
Goal
Перечень причинно самостоятельных идей серебряных пуль для продления жизни
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Mitochondrial maintenance complements senolysis
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    The processes that maintain mitochondria within cells

    Where this hypothesis actsIn and muscle fibers

    Hypotheses on this target 1
    Mitochondrial maintenanceInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Function preservation1
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Function preservation

    Restore

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible lasting multisystem benefit and lifespan gain when combined with senescent fibroblast removal

    From the recordM восстанавливает митохондриальное обслуживание кардиомиоцитов и мышечных волокон

  2. Senescent cell

    Senescent

    in a senescent state

    Where this hypothesis actsChronically senescent that hinder tissue recovery

    Hypotheses on this target 7
    Senescent fibroblastsFunction preservation. Hypotheses on this target 22Senolysis. Hypotheses on this target 22Senomorphic suppression. Hypotheses on this target 11Clearance restoration. Hypotheses on this target 11Reprogramming. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Function preservation2
    • Senolysis2
    • Senomorphic suppression1
    • Clearance restoration1
    • Reprogramming
    • Population balance

    What is proposed

    Senolysis

    Remove senescent

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible lasting multisystem benefit and lifespan gain when combined with restored

    From the recordC удаляет хронически сенесцентные фибробласты, мешающие восстановлению ткани.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblasts
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenance
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Repairing one source of age-related decline may leave another source capable of preventing lasting recovery. The unexpected move is to treat two different repairs as one combined answer to the search for an intervention that benefits several body systems and extends life. This is a proposal generated by the pipeline, not a measured result: neither repair alone is predicted to achieve the full benefit.

The proposed mechanism, link by link
  1. Restored upkeep repairs the maintenance of energy-producing structures inside heart and .
  2. Cell removal eliminates persistent growth-arrested tissue-support cells proposed to obstruct tissue repair.
  3. Either intervention alone improves its immediate target but leaves the other proposed source of functional decline active.
  4. Together, the interventions are predicted to remove both obstacles and permit lasting benefits across several body systems and longer life.
  5. Reducing substances released by the persistent cells is predicted to substitute for neither intervention and add no benefit beyond a predefined margin when both are already present.
A picture for it

A workshop may need both its machinery repaired and its blocked work areas cleared before it can operate reliably. Completing only one job can improve something locally while leaving the workshop unable to function as a whole.

Where the picture breaks: Cells can change one another's behaviour, so repairing one process might also restore the other. The picture illustrates the proposed requirement for two repairs; it provides no evidence that biology actually requires both.

  1. Master questionstep 01 of 04

    Age-related processes may reinforce one another, so changing a shared cause could benefit several body systems at once. The goal is to identify ideas that could extend life through such broad effects.

    Rests on: The goal explicitly gives mutual reinforcement between ageing processes as the reason to search for a shared cause.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The desired output is a collection of life-extension ideas that act through genuinely different causes.

    Rests on: The master question requests multiple ideas for interventions with broad benefits. Distinguishing their causes makes explicit what would make them separate ideas.

    Stated in the chain
  3. Gap questionstep 03 of 04

    The number of distinct ideas is to be determined by separately switching off and restoring the processes through which candidate interventions work. The distinction must survive comparison of lasting benefits across several body systems and effects on lifespan.

    Rests on: The previous stage requires ideas to be different in their causes. This stage supplies a proposed way to distinguish those causes by interrupting and restoring their effects.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    One combined idea is proposed to require exactly two interventions: restoring , the upkeep of energy-producing structures inside cells, in heart and ; and removing chronically senescent , tissue-support cells that persist in a state of lasting growth arrest with altered functions. Each intervention alone is predicted to improve its immediate target while leaving another required source of decline in place. Reducing substances released by the persistent cells is predicted to replace neither repair.

    Rests on: The preceding question supplies the requirement to distinguish causes through separate interruption and restoration. The endpoint supplies the specific biological premise that two different failures must both be corrected.

    Assumption

    The proposed premise is that neither maintenance of the energy-producing structures nor removal of the persistent tissue-support cells can compensate for failure of the other, and that their combination is sufficient for the full lasting benefit. The supplied material does not establish this joint necessity or sufficiency.

What is carried, and what is not. Three screened sources speak to components of the proposal: S6 in Circulation (2026) reports restored and maintenance of energy-producing structures alongside improvement in the studied heart-dysfunction models, but does not test cell removal, skeletal muscle, or lifespan; S3 in eLife (2022) reports that metformin reduces release of and from , but does not establish their removal or the proposed combined benefit; and the abstract supplied for S9 in Biochimica et Biophysica Acta, Molecular Basis of Disease (2023) links persistent with tissue scarring and organ dysfunction, but does not test either intervention or their combination. These are supports for individual components, not the sequence as a whole: none of the supplied sources establishes that exactly these two interventions are jointly necessary and sufficient for lasting benefits across several body systems and longer life.S6S3S9

Where the reasoning is carried by something unstated · 1
  • Hypothesis. The proposed premise is that neither maintenance of the energy-producing structures nor removal of the persistent tissue-support cells can compensate for failure of the other, and that their combination is sufficient for the full lasting benefit. The supplied material does not establish this joint necessity or sufficiency.
How a result here could mislead · 3
  • Failure of either intervention alone could be read as evidence that both are necessary when the intervention did not adequately change its intended process, or the measurements were too uncertain to detect a useful effect. What closes it: The proposal requires verified effects on each intended process at several acceptable intervention intensities. It also requires , ranges expressing uncertainty around an estimated effect, that exclude a useful benefit defined before testing; a result that merely fails a is insufficient.
  • Benefit after cell removal could be credited to a separate repair process even if removal also restores maintenance of energy-producing structures in neighbouring cells, as one rival proposes. Likewise, loss of benefit after switching off one process could reflect unintended disruption of both. What closes it: Both processes must be measured under each intervention and during their separate interruption and restoration. The claimed specificity of those manipulations must be demonstrated so that a second process changing indirectly is distinguishable from two processes being independently required.
  • A combination could appear uniquely successful because the definition of overall success was chosen after seeing which outcomes improved. Failure to detect an extra benefit from reducing could also be mistaken for evidence that the addition makes no meaningful difference. What closes it: The common success criterion, the required duration of benefit, the body-system outcomes, and the lifespan outcome must be fixed before testing. The , the largest difference accepted as meaningfully negligible, must also be fixed in advance and assessed with uncertainty estimates. The supplied specification gives no numerical thresholds, durations, or margin.

What would make this wrong. The claim that both repairs are necessary would fail if either intervention alone met the predefined criterion for lasting benefits across several body systems and longer life, with its intended process verified as changed. It would also fail if the combined benefit persisted when either proposed required process was specifically switched off. The claim of sufficiency would fail if both processes were successfully restored together but the combination did not meet the success criterion. A reproducible added benefit from reducing beyond the predefined would contradict the endpoint's prediction that this addition provides no meaningful further benefit.

What it would change. If the predicted pattern held, the search for broadly effective life-extension ideas would have to count this pair as one combined idea whose benefit requires both parts. Within the tested set, identifying different biological targets would no longer be enough to count separate sufficient interventions. That result would still not establish the combination's effects in humans, other tissues, or over other timescales: the supplied testing outline does not specify the species or duration, and it cannot establish how many such ideas exist outside the candidate set.

Sources read · 10

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Contradicts it

Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A. · Nutrients · 2026

“In aged mice, continuous dietary administration of fisetin (500 mg/kg diet) beginning at 85 weeks of age significantly extended both median and maximum lifespan.”

Does not settle: Источник не проверяет сочетание митохондриального обслуживания с удалением сенесцентных клеток, не устанавливает минимальный достаточный набор {M,C} и не показывает, что оба процесса необходимы для многосистемного или жизненного выигрыша.

S2Background

ApoD mediates age-associated increase in vulnerability to influenza virus infection. · Proceedings of the National Academy of Sciences of the United States of America · 2025

“Removal of senescent cells in aged lung using the senolytic drug ABT-263 reduced ApoD levels, and alleviated pulmonary pathology in response to influenza virus infection.”

Does not settle: Источник не проверяет совместное применение двух вмешательств, их минимальную достаточность или необходимость для продления жизни. Он также не изучает обслуживание митохондрий в кардиомиоцитах и мышечных волокнах, удаление сенесцентных фибробластов, многосистемный функциональный выигрыш или роль R.

S3Partly answers it

Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. · eLife · 2022

“Together, these data indicate that low, therapeutically relevant concentrations of metformin reduce the release of ROS and SASP cytokines from senescent cells, which can explain the senostatic activity of metformin in vivo.”

Does not settle: The source does not test a two-intervention set combining mitochondrial maintenance in cardiomyocytes or muscle fibres with clearance of senescent fibroblasts. It does not show senescent-cell removal, necessity of either intervention, their functional complementarity, or a long-term multisystem or lifespan benefit from their combination.

S4Background

The role of mitochondria in cellular senescence. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021

“Together, these observations suggest that mitochondria are intimately involved and potentially required for the induction and maintenance of the senescent state.”

Does not settle: Источник оставляет открытыми совместное применение M и C, восстановление митохондриального обслуживания кардиомиоцитов и мышечных волокон, удаление хронически сенесцентных фибробластов, минимальность набора {M,C}, а также длительный многосистемный выигрыш и продление жизни.

S5Partly answers itAbstract only

Beneficial effects of spermidine on cardiovascular health and longevity suggest a cell type-specific import of polyamines by cardiomyocytes. · Biochemical Society transactions · 2019

“Recent and exciting in vivo studies show that supplementation with the polyamine spermidine (Spd) is cardioprotective and prolongs lifespan in both mice and humans.”

Does not settle: It does not establish removal of senescent fibroblasts, a two-intervention set {M,C}, their necessity or sufficiency for multisystem longevity, or that either intervention alone leaves a separate required cause of decline.

S6Partly answers it

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis. · Circulation · 2026

“both genetic and pharmacological inhibition of KIF11 effectively restored autophagic flux and mitochondrial homeostasis, thereby reversing pathological cardiac remodeling in Asb2-deficient hearts and transverse aortic constriction-induced cardiac dysfunction.”

Does not settle: Источник не исследует удаление сенесцентных фибробластов, совместное применение двух воздействий, скелетные мышечные волокна, многосистемный эффект или продолжительность жизни.

S7Background

Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia. · International journal of molecular sciences · 2022

“Figure 1 Schematic Representation of the Coordinated Regulation of the Mammalian Target of Rapamycin and Mitophagy in Muscle Protein Synthesis and Degradation.”

Does not settle: Источник не устанавливает, что сочетание M и C необходимо или достаточно для продления жизни; он не сообщает об удалении сенесцентных фибробластов, кардиомиоцитах, многосистемном эффекте или сравнении отдельных и совместных вмешательств.

S8Background

Editorial: Mitochondria in Skeletal Muscle Health, Aging and Diseases. · Frontiers in physiology · 2016

“a growing interest now surrounds mechanisms involved in mitochondrial quality control (i.e., mechanisms responsible for the degradation of damaged / dysfunctional mitochondria).”

Does not settle: Источник не проверяет вмешательства M, C или R, их совместное применение, удаление сенесцентных фибробластов, минимальность набора {M,C}, многосистемный эффект или продление жизни.

S9BackgroundAbstract only

Senescent cardiac fibroblasts: A key role in cardiac fibrosis. · Biochimica et biophysica acta. Molecular basis of disease · 2023

“However, the persistent presence of senescent cells within a tissue is linked with fibrosis development and organ dysfunction, leading to aging-related diseases such as cardiovascular pathologies.”

Does not settle: It does not test removal of senescent fibroblasts, mitochondrial upkeep, their combination, or effects on lifespan or multisystem function.

S10Background

Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis. · American journal of physiology. Lung cellular and molecular physiology · 2018

“Normally, once a senescent cell has contributed to wound repair, it is promptly removed from the environment via infiltrating immune cells. However, if immune clearance fails, the persistence of senescent cells is thought to drive disease pathology through their altered secretory profile.”

Does not settle: Источник не устанавливает, что удаление сенесцентных фибробластов является вмешательством C, и не оценивает совместное применение C с митохондриальным обслуживанием M. Он не сообщает о кардиомиоцитах, мышечных волокнах, продолжительности жизни, многосистемном эффекте или минимальном достаточном наборе {M,C}.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сколько причинно самостоятельных идей «серебряных пуль» содержит проверяемый набор , если должно определить, какие воздействия остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?

What this question is asking

The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring —the biological steps through which an intervention produces its effects—can distinguish interventions by their lasting benefits across several body systems and their effects on lifespan. Interventions would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared and limits on the benefit available may make different interventions look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.

What the terms mean
Biological target
A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
Intervention
A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, interventions are compared by their biological dependencies and lasting outcomes.
Mediator and biological dependency
A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
Disabling and restoration
Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
Causally independent routes and causal equivalence
These describe whether interventions work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
Ceiling on benefit
A limit beyond which a measured benefit no longer increases. Such a limit could make different interventions look similar, but its role in the intended target collection is not established.
Muscle stem cells and activation
Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
Cyclin D1
A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
Genes and genetically altered model
Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
Autophagy
A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
Dietary restriction
Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
Insulin sensitivity
How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
Oxygen-dependent metabolism
The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the interventions work.
Littermates
Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
What the question takes for granted
Premise only partly supported
Separate disabling and restoration of can determine which interventions remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.

A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of interventions into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.

S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6

The same question asked without the part nothing read establishes:

  • Which interventions in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
  • What do the read sources establish about whether the candidate interventions depend on the same biological steps for their benefits?
What turns on the answer
  • Several targets reduce to fewer routes If the dependency tests showed that differently named interventions produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
  • Several routes remain distinguishable If interventions retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
  • The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the interventions were equivalent or whether the comparison could not distinguish them.
Why it matters

An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several interventions depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the interventions work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.

What is already established

S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, не подсчитаны.

What would have to be true

Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем .

What is missing

Число названных неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие и могут скрывать различия.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

В наборе содержится одна составная самостоятельная идея с {,}, включающим ровно два воздействия. восстанавливает и , удаляет хронически сенесцентные , мешающие восстановлению ткани. Взаимное функциональное дополнение этих процессов необходимо для длительного : каждый по отдельности улучшает ближайший показатель, но сохраняет вторую обязательную причину функционального ухудшения. уменьшает , однако не заменяет ни обслуживание , ни удаление клеток. Каталог имеет вид {{,}}. Удаление любого элемента из этого набора лишает его достаточности.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Из семи активных сочетаний проходят только + и ++; добавление к + не улучшает результат сверх заранее заданной . Ни , ни по отдельности не достигают критерия даже при и при нескольких допустимых уровнях интенсивности. любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. , ожидаемая в гипотезе 01, или , ожидаемая в гипотезах 02 и 03, опровергает этот набор.

Would tell it apart from at least one rival. The prediction specifies success comparisons, an equivalence condition, and loss and restoration of benefit following process removal and return. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

позволяет проверить обязательность сочетания. Для вывода о одиночных воздействий нужны , исключающие ; простой недостаточен.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Из семи активных сочетаний проходят только + и ++; добавление к + не улучшает результат сверх заранее заданной . Ни , ни по отдельности не достигают критерия даже при и при нескольких допустимых уровнях интенсивности. любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. , ожидаемая в гипотезе 01, или , ожидаемая в гипотезах 02 и 03, опровергает этот набор.

  • What would separate them

    Restoring mitochondrial renewal may account for all lasting benefits of the tested interventions predicts: При подтверждённом удалении и снижении их мягкое выключение только в сохраняющихся полностью устраняет длительную пользу и . Возврат восстанавливает пользу. Напротив, изолированное сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа и их около исходного уровня. Такой результат отличает единственный достаточный элемент {} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.

  • What would separate them

    Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания перестаёт давать дополнительный длительный эффект. сохраняет пользу при умеренном ; сохраняет пользу при снижении . Возврат соответствующего восстанавливает только его ветвь. переработки материала показывает два независимо изменяемых . В отличие от гипотезы 01, способен приносить пользу при ограниченном ; в отличие от гипотезы 03, не сохраняет отдельного эффекта при фиксированном ; в отличие от гипотезы 04, проходят .

  • What would separate them

    Organelle upkeep, secretion control and cell removal may independently extend life predicts: Каждое одиночное воздействие проходит и сохраняет часть пользы при двух других процессов. Для подавление устраняет удаление клеток и длительный эффект; возврат восстанавливает оба результата. и сохраняют пользу в тех же условиях. Особенно различающий результат: улучшает функции и при и числе .

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.